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Horizontal gene transfer (HGT) is the major mechanism responsible for spread of
antibiotic resistance. Antibiotic treatment has been suggested to promote HGT, either
by directly affecting the conjugation process itself or by selecting for conjugations
subsequent to DNA transfer. However, recent research suggests that the effect of
antibiotic treatment on plasmid conjugation frequencies, and hence the spread of
resistance plasmids, may have been overestimated. We addressed the question by
quantifying transfer proteins and conjugation frequencies of a blaCTX−M−1 encoding
IncI1 resistance plasmid in Escherichia coli MG1655 in the presence and absence of
therapeutically relevant concentrations of cefotaxime (CTX). Analysis of the proteome by
iTRAQ labeling and liquid chromatography tandem mass spectrometry revealed that Tra
proteins were significantly up-regulated in the presence of CTX. The up-regulation of the
transfer machinery was confirmed at the transcriptional level for five selected genes. The
CTX treatment did not cause induction of the SOS-response as revealed by absence
of significantly regulated SOS associated proteins in the proteome and no significant
up-regulation of recA and sfiA genes. The frequency of plasmid conjugation, measured
in an antibiotic free environment, increased significantly when the donor was pre-grown
in broth containing CTX compared to growth without this drug, regardless of whether
blaCTX-M-1 was located on the plasmid or in trans on the chromosome. The results shows
that antibiotic treatment can affect expression of a plasmid conjugation machinery and
subsequent DNA transfer.
Keywords: antibiotic resistance, plasmid transfer, conjugation, Tra-proteins, Escherichia coli
INTRODUCTION
Plasmid conjugation contributes significantly to horizontal spread of antibiotic resistance, because
antibiotic resistance genes are frequently located on plasmids (Zatyka and Thomas, 1998; Sorensen
et al., 2005; Thomas and Nielsen, 2005; Bennett, 2008; Norman et al., 2009). However, whether
antibiotic treatment increases the transfer rate per se is debatable. This question is not easily
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answered. A recent publication has reviewed a number of
published conjugation experiments and pointed to the fact
that the typical experimental setup cannot distinguish between
increased transfer efficacy and selective growth advantage for
the transconjugants in the presence of the antibiotic (post
transfer). This report concluded that antimicrobials only serve
to select for transconjugants, and that sub-lethal concentrations
of antibiotics from the most widely used antimicrobial classes
do not significantly increase the conjugation efficiency (Lopatkin
et al., 2016a).
Beaber et al. (2004) reported that induction of the SOS-
response by either mitomycin C or ciprofloxacin treatment
enhanced the transfer of SXT, an integrative and conjugative
element, which encodes antimicrobial resistance in Vibrio
cholerae (Waldor et al., 1996), and in Staphylococcus aureus, the
transfer of a resistance-plasmid carrying tetracycline resistance
was reported to be greatly enhanced by the presence of
sub-inhibitory concentrations of β-lactam antibiotics, also
due to induction of the SOS-response (Barr et al., 1986).
Similarly, treatment with sub-inhibitory concentrations of
several antibiotics has been shown to induce the expression of
conjugative transfer genes from an R-plasmid in Aeromonas
hydrophila (Cantas et al., 2012), and low concentrations of
tetracycline has been reported to increase transfer of conjugative
transposons in strains of Bacteroides by a factor 10–100 (Whittle
et al., 2002).
Plasmid conjugation in Gram-negative bacteria primarily
occurs via type IV secretion (T4S), where single stranded plasmid
DNA is transported between two cells forming a mating pair.
The transfer is mediated by a multi-protein complex extending
across the cell envelope of both the donor and recipient cells
(Goessweiner-Mohr et al., 2013; Christie et al., 2014). Generally
it is composed of ATPases, translocon proteins of the inner
membrane, core proteins spanning the cell envelope and pilus
proteins (Koraimann and Wagner, 2014). The IncF plasmid-
group is a model for conjugative plasmids. In this group,
more than 25 transfer genes (tra genes) are organized in a
single continuous region called the transfer region (Komano
et al., 1990; Zatyka and Thomas, 1998; Koraimann and Wagner,
2014; Singh and Meijer, 2014). To minimize the host burden,
expression of these genes is tightly regulated, and conjugation
is only switched on under conditions that favor transfer of
the conjugative element (Komano et al., 1990; Zatyka and
Thomas, 1998; Koraimann and Wagner, 2014; Singh and Meijer,
2014). The majority of the genes are co-transcribed from a
common promoter (Frost et al., 1994), which is activated by
the two-component response regulator, ArcA, and the plasmid-
specific positive regulator, TraJ (Silverman et al., 1991; Frost
and Koraimann, 2010). IncI1 plasmids, such as R64, ColIb-P9
and R144 use a conjugation system very similar to that of the
IncF plasmids, but with distinctive differences (Komano et al.,
1990, 2000). They encode for two types of sex pili, a thin flexible
pilus and a thick rigid pilus, both of which are antigenically and
morphologically different from the IncF pilus (Komano et al.,
1990, 2000), and the tra-region consists of approximately 30
transfer-related genes, the products of which share the same
principal function as their IncF-encoded counterparts (Komano
et al., 2000; Frost and Koraimann, 2010). IncI1 plasmids carry
the sog gene which encodes DNA primase which is responsible
for suppressing dnaG mutations in Escherichia coli, and IncI1
plasmids show a complex DNA rearrangement mediated by a
unique structure designated shuﬄon (Komano et al., 1990).
Cephalosporinases, encoded by Extended Spectrum β-
Lactamases (ESBLs), are a common cause of β-lactam resistance,
particularly in E. coli and Klebsiella pneumonia (Lawley
et al., 2003; Ilangovan et al., 2015). CTX-M-1, encoded from
blaCTX-M-1, is among the most common ESBL gene, and this
gene is often plasmid-encoded (Rodríguez et al., 2009). In the
current study we used this gene, located on a naturally occurring
IncI1 plasmid pTF2, to study the effect of cephalosporin
treatment on the conjugation machinery and on conjugation
frequencies. Importantly, we designed an experimental setup
for measurement of conjugation frequency, in which we could
separate conjugation rate from the power of selection by the
antibiotic. Our results revealed an increased cephalosporin
dependent conjugation frequency, thus contributing with novel
insight to the on-going debate on the role of antimicrobial
treatments in the spread of plasmid-encoded resistance.
MATERIALS AND METHODS
Bacterial Strains and Plasmids
The native IncI1 plasmid pTF2 carrying blaCTX-M-1 was isolated
from a commensal E. coli of cattle origin. It had the typical
IncI1 plasmid scaffold and did not harbor genes for resistance
to additional therapeutic antimicrobials (accession number
KJ563250). E. coli K-12 MG1655/pTF2 (Kjeldsen et al., 2015a),
was used for protein and gene expression studies and as donor
strain in conjugation experiments. E. coli MG1655/pTF21CTX
(Kjeldsen et al., 2015b) containing a non-coding sequence (NCS)
instead of blaCTX-M-1 on the IncI1 plasmid pTF2 was used as a
control strain. The NCS was constructed by randomly shuﬄing
the sequence of blaCTX-M-1(Kjeldsen et al., 2015b), thus creating
a sequence of the exact same length as the original gene, but
with no open reading frame. Additionally, a strain (E. coli
MG1655/CTX-M-1/pTF21CTX), containing a NCS instead of
blaCTX-M-1 on the IncI1 plasmid pTF2, and with CTX-M-1
encoded on the chromosome, was constructed in the current
study by conjugating the pTF21CTX plasmid from E. coli
MG1655/pTF21CTX into E. coli MG1655/CTX-M-1 (Kjeldsen
et al., 2015a), which carries the blaCTX-M-1 on the chromosome.
Strains and plasmids used are listed in Table 1. Screening for
plasmid carrying strains among CTX resistant strains was done
by PCR directed against traU. Primer sequences are shown in
Supplementary Table S1. A rifampicin-resistant strain of E. coli
J53-2 was used as recipient in conjugation experiment.
Growth Conditions
For protein and gene expression analysis, strains were grown in
250mL flasks containing 100mL of Mueller Hinton II (MH-2)
broth (Sigma, Copenhagen, Denmark) at 37◦C with shaking at
225 rpm. In addition to growth in antibiotic free medium, the
medium was supplemented with two different concentrations of
cefotaxime (CTX) (Sigma, Copenhagen, Denmark) representing
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TABLE 1 | Strains and plasmids used in the study.
Name Genotype References
PLASMID
pTF2a blaCTX-M-1 containing IncI1
plasmid pTF2 (ampr)
Kjeldsen et al., 2015a
pTF21CTX pTF2 with non-coding sequence
inserted instead of CTX-M-1
Kjeldsen et al., 2015b
STRAIN
MG1655/pTF2 E. coli MG1655/pTF2 (ampr) Kjeldsen et al., 2015a
MG1655/
pTF21CTX
E. coli MG1655/pTF21CTX Kjeldsen et al., 2015b
MG1655/CTX-M-1 E. coli MG16551YbeM::CTX-M-1
(ampr)
Kjeldsen et al., 2015a
MG1655/CTX-M-
1/pTF21CTX
E. coli MG16551YbeM::CTX-M-
1/pFT21CTX (ampr)
This work
J53-2 E. coli J53-2, recipient strain (rifr) Appelbaum et al., 1972
aAccession number KJ563250.
½MIC of the blaCTX-M-1 strain (126 mg/L) and 1/100MIC of the
E. coli K-12 MG1655 strain (0.016 mg/L) (Blattner et al., 1997).
The high CTX concentration is within the range of therapeutic
concentrations, as previously reported (Fu et al., 1979; Raddatz
et al., 1995). Pre-cultures grown for 2 h at 37◦C and 225 rpm
were used to inoculate the cultures to a final cell density of 105
CFU/mL. Growth was monitored by measuring optical density
(OD600), and samples were taken in the exponential growth phase
(OD600 = 0.5).
Growth of cells for measurement of effects of short time
CTX treatment was performed by growing cultures, inoculated as
described above, until they reached a cell density at OD600 = 0.5.
At this point they were treated with 0 mg/L or 126 mg/L CTX for
5, 10, and 20min before samples were taken for RNA extraction.
In parallel, CFU of cultures were determined by plating 10-fold
dilutions on LB-agar plates. Counts were made after incubation
for 18 h at 37◦C. All experiments were performed in biological
duplicates or triplicate with two-three technical replicates each.
Proteomics
Reduction, Alkylation and Proteolytic Digestion
The culture samples were harvested and resuspendend in 300µL
sonication buffer [6M urea, 2M thiourea, 100mM ammonium
bicarbonate (all from Sigma, Copenhagen, Denmark)] pH
8.0 supplemented with EDTA-free protease inhibitor cocktail
(complete ULTRA tablets, Roche, Hvidovre, Denmark). The
resuspended cell pellets were sonicated on ice seven times for
15 s each at 70W. Proteins in cell lysate (typically 100µL)
was reduced in 10mM dithiothreitol (DTT) for 1 h at 25◦C
and alkylated with 50mM iodoacetamide for 40min at 25◦C
in the dark. Each sample was diluted 1:10 with 50mM
triethylammonium bicarbonate (TEAB) pH 8.0 and proteins
were digested with 2% (w/w) trypsin for 16 h at 25◦C. The
peptide suspension was desalted using Oasis HLB Plus short
cartridges (Waters, Hedehusene, Denmark) as recommended by
the manufacturer and finally dried by vacuum centrifugation and
stored at−20◦C.
iTRAQ Labeling
iTRAQ labeling was performed with the 4-plex iTRAQ reagents
as recommend by the manufacturer (Applied Biosystems,
Naerum, Denmark). Briefly, 10µg peptide digest (as determined
by amino acid analysis) was labeled at room temperature for 1 h
after which 4µL from each mass tag reaction was withdrawn,
combined and analyzed by MALDI-TOF/TOF (UltraFlex II,
Bruker Daltonics, Bremen) in order to estimate the relative ratios
of each label. Appropriate samples amounts were pooled and
dried by vacuum centrifugation. The iTRAQ sample was re-
suspended in 50µL 0.1% trifluoroacetic acid (TFA), desalted
using Poros R3 micro-columns (Rappsilber et al., 2007), dried by
vacuum centrifugation and stored at−20◦C.
Liquid Chromatography Tandem Mass Spectrometry
(LC–MS/MS)
Peptides were analyzed by an Easy-nLC and nanospray source
(Thermo Fisher Scientific, Bremen, Germany) coupled with a
Q-Exactive Plus mass spectrometer (Thermo Fisher Scientific,
Bremen, Germany). Approximately 1µg of labeled peptide
(5µL) was reconstituted in 0.1% formic acid and loaded onto
a trap column at 250 bar [2 cm length, 100µm inner diameter,
ReproSil, C18 AQ 5µm 120 Å pore (Dr. Maisch, Ammerbuch,
Germany)] vented to waste via a micro-tee and eluted across
a fritless analytical in-house packed resolving column (17 cm
length, 75µm inner diameter, ReproSil, C18 AQ 3µm 120 Å
pore) with a 107min gradient of 0–30% LC-MS buffer B (LC-
MS buffer A: 0.1% formic acid; LC-MS buffer B: 0.1% formic
acid, 95% ACN) using a flow rate of 300 nL/min. Instrument
method consisted of one survey scan (AGC target value: 1e6;
R = 70K; maximum ion time: 120ms; mass range: 400–1,400
m/z) followed by data-dependent tandemmass spectra on the top
12 most abundant precursor ions [isolation width: 1.6 m/z; HCD
collision energy (NCE): 32; MS1 signal threshold: 2e4; AGCMS2
target value: 1e6; maximum MS/MS ion time: 200ms; dynamic
exclusion: repeat count of 1, maximum exclusion list size, 20 s
wide in time, ±10 ppm wide in m/z; doubly-charged precursors
only; minimum signal threshold of 10,000].
Proteomics Data Process and Database Search
The LC-MS/MS data were processed with Proteome Discoverer
(Version 1.4.1.14, Thermo Fisher Scientific, Bremen, Germany)
and subjected to database searching using an in-house Mascot
server (Version 2.2.04, Matrix Science Ltd., London, UK).
Database searches were performed with the following
parameters: Database, NCBI sub-taxonomy E. coli; Trypsin
as the enzyme allowing a maximum of one missed cleavages
sites; Carbomidomethylation of Cys as fixed modification;
Deamidation of Asn and Gln; Oxidation of Met allowed as
variable modification; iTRAQ was set as variable modification.
Precursor and fragment mass tolerance were set to 10 ppm
and 0.05 Da, respectively. Precursor mass range set from 350
to 7,000 Da. Protein identification was based on at least two
unique peptides. False discovery rate was set to 1% at protein
level using the Percolator algorithm. iTRAQ quantification
was performed using Proteome Discoverer. The ratios were
normalized against the protein median. The proteomics were
Frontiers in Microbiology | www.frontiersin.org 3 November 2017 | Volume 8 | Article 2365
Møller et al. Antibiotic Treatment and Conjugation Transfer Frequency
performed in biological duplicates using two technical replicates.
A threshold of 1.5 was used for identification of up-regulated
proteins. Please use project number PXD006679 to access all
generated MS/MS data stored in the PRIDE archive (https://
www.ebi.ac.uk/pride/archive/).
RNA Extraction
At each sampling point from the proteomic study, a volume of
0.5mL cell sample was mixed with 1mL of RNAlater (Ambion R©,
Naerum, Denmark) according to the manufacturer’s instructions
and stored for immediate stabilization and protection of the
RNA. A FastPrep cell disrupter system (Qbiogene, Illkirch,
France) and an RNeasy Mini kit (Qiagen, Sollentuna, Sweden)
was used to extract total RNA bymechanical disruption. Quantity
of the extracted RNA was determined by A260 measurements and
purity by A260/A280 ratio measurements using a NanoDrop 1000
spectrophotometer (Thermo Scientific, Hvidovre, Denmark).
The total RNA was treated with TURBOTM DNase (2 U/µL)
(Ambion R©, Naerum, Denmark).
Reverse Transcribed-Quantitative Real
Time Polymerase Chain Reaction
(RT-qPCR)
One hundred and fifty nanograms of purified RNA were reversed
transcribed with the High Capacity cDNA Reverse Transcription
Kit (Life Technologies, Naerum, Denmark) according to the
manufacturers’ instructions. qPCR was performed essentially as
described by Pfaﬄ, using a LightCycler 96 (Roche, Hvidovre,
Denmark) (Pfaﬄ, 2001). The genes gapA and nusG were used as
reference genes based on validation performed in another study
(Kjeldsen et al., 2015a). The 2−11CT method was used, however
corrected for different primer efficiencies and multiple reference
genes (Pfaﬄ, 2001). Two independent biological replicates were
performed using two technical replicates. Primer sequences can
be seen in Supplementary Table S1.
Conjugation Experiment
MG1655/pTF2 was used as donor and J53-2 as recipient
strain in the conjugation experiments aiming to determine
the conjugation transfer frequency when the CTX-M-1 gene
was located on the IncI1 plasmid pTF2. MG1655/pTF2
was grown with and without CTX (126 mg/L) up to an
OD600 = 0.5. In order to remove antibiotics from the donor
strains, cells were washed in LB medium by centrifugation at
1,000 g for 3min at room temperature, and then resuspended
in fresh LB medium and adjusted to OD600 = 0.5. The
recipient was grown without CTX to the same OD. The
conjugations were performed on DifcoTM lysogeny broth (LB)
agar plates (Becton, Dickinson, Albertslund, Denmark) with
filters (0.22µM, Millipore, Copenhagen, Denmark) at 37◦C.
Donor (grown with and without antibiotics) and recipient
were mixed in a 1:1 ratio to a final volume of 200µl on the
filters. This approach ensured that none of the antimicrobial
that had been used in the pre-growth was present during
the conjugation experiment. Mixtures were incubated at 37◦C
without shaking and conjugation was performed for 30 and
60min. The bacterial material was washed of the filters using
isotonic NaCl and the mixture was vortexed to stop the
conjugation process. A dilution series was made and the mixture
was plated onto LB agar plates containing 5 mg/L CTX (for
quantifying donor+transconjugants), 50 mg/L rifampicin (for
quantifying recipient+transconjugants) or 5 mg/L CTX and
50 mg/L rifampicin (for quantifying transconjugants only) and
incubated overnight at 37◦C. The conjugation frequency was
calculated as transconjugants divided by number of donors
times 100.
To confirm the counting of transconjugants by an
independent method, colonies growing on LB agar plates
containing 50 mg/L rifampicin (recipient and transconjugants)
were scraped off and DNA was extracted using DNeasy Blood
& Tissue Kit (Qiagen, Hilden, Germany). The concentrations
and the quantity of the extracted DNA were determined by
a NanoDrop 1000 spectrophotometer (Thermo Scientific,
Hvidovre, Denmark). The number of transconjugants was
determined by qPCR using previously published primers
targeting 16s rDNA as the reference gene (Suzuki et al., 2000;
Luprano et al., 2016) for number of bacteria, and primers
targeting traF (Supplementary Table S1) to count the number
of transconjugants. Note that this was done on DNA level, and
thus the fact that traF is up-regulated in the presence of high
concentrations of CTX is irrelevant.
E. coli MG1655/CTX-M-1/pTF21CTX was used as donor
and J53-2 was used as recipient to determine the conjugation
transfer frequency when the CTX-M-1 gene was located on the
chromosome. E. coliMG1655/CTX-M-1/pTF21CTX was grown
with and without CTX (84 mg/L = ½ MIC of this strains) up
to an OD600 = 0.5. In order to remove antibiotics from the
donor strains, an additional washing step was also performed as
mentioned above. The recipient was grown without CTX to the
same OD600, and the conjugation experiments were performed
for 30 and 60min as described above. Antibiotics used in this
study were purchased from Sigma (Copenhagen, Denmark). The
experiments were performed in at least biological duplicates with
two technical replicates each.
Statistical Analysis
Statistical analysis was performed using GraphPad prism version
6. Protein expression and gene expression was compared for
the same protein/gene between conditions using One way
ANOVA with Bonferreti’s correction for multiple comparisons
(between 0, 1/100MIC and½MIC concentrations of antibiotics).
Comparison of conjugation frequencies with and without added
antimicrobial was performed by students t-test with Welch’s
correction. A P < 0.05 was considered significant.
RESULTS
A likely mechanism for antimicrobials to promote an increase
in the number of conjugation events is to promote up-
regulation of the T4S responsible for the conjugative transfer.
In order to study whether the 3rd generation cephalosporin,
CTX, affected expression of the conjugation apparatus of the
IncI1 plasmid pTF2, we performed iTRAQ-based quantitative
proteome analysis. The relative protein levels of E. coli strain
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MG1655/pTF2, carrying blaCTX-M-1 on pTF2, exposed to low
(0.016 mg/L) and high (126 mg/L) concentrations of CTX,
respectively, was determined relative to the isogenic control
strain grown without CTX. The results showed that Tra-proteins
and other conjugation related proteins were significantly up-
regulated in the presence of high levels of CTX (One-way
ANOVA, 0.0001 < P < 0.05 depending on the protein),
while bacteria grown at the low concentrations of CTX
showed insignificant differences in the proteome compared to
the untreated control (One-Way ANOVA with correction for
multiple comparison, p> 0.05). Nine out of ten plasmid transfer-
related proteins detected in the analysis were up-regulated 2-
to 3-fold, while the remaining protein (PilN) was up-regulated
nearly 2-fold (Figure 1). Apart from the CTX-M-1 β-lactamase
and a predicted HEAT domain containing protein (accession
number: 585322259), no other proteins were found to be
significantly up regulated as a result of CTX treatment. The full
proteome data set is presented in Supplementary Dataset S1.
The up-regulation of transfer proteins in response to high
doses of CTX was confirmed at the transcriptional level for
five selected genes using RT-qPCR analysis (Figure 2). These
genes were selected to represent the pilus synthesis and assembly
system (traF and traL), the DNA transfer system (traI and traM)
and the structural components of the pilus (pilS). Significant
up-regulation (30- to 80-fold, One-Way ANOVA, 0.0001 <
P < 0.001 depending on the gene) was observed when the
bacterium was treated with high CTX concentrations during
growth. In contrast, low CTX concentrations had no significant
FIGURE 1 | Relative protein ratios for proteins involved in conjugation for
MG1655/pTF2. Relative protein levels were determined by iTRAQ. Cell
samples grown at no (0 mg/L), sub-therapeutic (0.016 mg/L), and therapeutic
(126 mg/L) concentrations of cefotaxime (CTX) were used for proteomics. The
results shown are from two biological replicates with two technical replicates
each. The data shown represents the mean and the error bars represent
standard deviations. The stars indicate statistical significance at different levels:
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001.
effect on conjugation gene transcription (One-Way ANOVA,
p > 0.05). Thus treatment with high concentration of CTX
caused up-regulation of the conjugation transfer system both at
the transcriptional and translational level.
To investigate if the induction of transfer gene expression
depended on the presence of the antibiotic resistance gene,
blaCTX-M-1, a strain carrying a NCS in the plasmid instead of
the resistance gene, MG1655/pTF21CTX, was treated with a
high concentration of CTX (126mg/L) for a short period of
time (20min). Time kill curve established that at this time point,
CFU of MG1655/pTF21CTX grown in the presence of CTX
did not differ significantly from CFU of the same strain grown
without CTX, while at later time point it was significantly reduced
(Supplementary Figure S1). The results showed that tra-gene
mRNA levels in this strain were not different from the non-
CTX treated control (t-test, p > 0.05), whereas the expression
of the transfer genes traF and traM was significantly induced
in the blaCTX-M-1 encoding isogenic strain after this 20min of
CTX treatment (Figure 3; t-test, p = 0.0051 and p = 0.0132).
Expression of pilS and traL was not significantly up-regulated
at this time point, but an increasing trend was seen. traI did
not show up-regulation at this time point. A similar difference,
yet not so pronounced, was observed at 5 and 10min samples
(data not shown). Together the results showed that up-regulation
of tra-genes due to treatment with CTX was dependent of the
presence of the resistance gene, blaCTX-M-1 in the strain. In order
FIGURE 2 | Expression of five selected transfer genes involved in conjugation
in MG1655/pTF2. Fold change in mRNA levels were determined by qPCR. Cell
samples grown at no (0 mg/L), sub-therapeutic (0.016 mg/L), and therapeutic
(126 mg/L) concentrations of cefotaxime (CTX) were used for qPCR. Two
independent replicates including two technical replicates each were
performed; the data shown represents the mean and the error bars represent
standard deviations. The data have been normalized to two validated
reference genes, gapA and nusG. The stars indicate significant difference
between 126 mg/L CTX and the other data points within each gene. The stars
indicate statistical significance at different levels: **P ≤ 0.01, ***P ≤ 0.001, and
****P ≤ 0.0001.
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FIGURE 3 | Expression of selected genes involved in conjugation in two
strains, MG1655/pTF2 (blaCTX-M-1) and MG1655/pTF21CTX (NCS) after
treatment with CTX for short time. Relative mRNA levels were determined by
qPCR. Cell samples were grown to exponential phase and then exposed to no
(0 mg/L) or therapeutic concentrations of CTX (126 mg/L) for 20min. The
expression data was normalized to two validated reference genes, gapA and
nusG. The results shown are means from two biological replicates with two
technical replicates each and the error bars represent standard deviations. The
stars indicate statistical significance at different levels: *P < 0.05, **P ≤ 0.01.
to rule out that the up-regulation was caused by a change in copy
number of the plasmid relative to the chromosome, we carried
out a qPCR based analysis. The ratio between a plasmid gene
(traF) and dxs in the chromosome did not change significantly
due to treatment with CTX in neither MG1655/pTF2 nor
MG1655/CTXM-1/pTF21CTX (Supplementary Figure S2).
In order to investigate whether up-regulation of the plasmid
transfer system would lead to increased number of conjugation
events, a conjugation experiment was performed in which we
separated antibiotic treatment from the conjugation and the
following selection for transconjugants. The MG1655/pTF2
strain was grown in the presence of CTX under the same
conditions as for the proteome analysis, allowing the
expression of conjugative transfer proteins. Conjugation
was then performed by filter-mating for 30 or 60min on agar
plates without antimicrobials, after which conjugation was
interrupted by centrifugation, before transconjugants were
selected. A significantly increased number of transconjugants,
corresponding to 8.4- and 6.6-fold higher conjugation transfer
frequencies, were seen after 30 and 60min of cell contact
compared to conjugation experiments in which the donor
was not grown in the presence of CTX before the conjugation
(t-test, p < 0.01; Figure 4). The increased conjugation transfer
frequencies were confirmed by performing the same experiment
FIGURE 4 | Conjugation-transfer-frequency for the plasmid pTF2 in
MG1655/pTF2 grown with (bar CTX) or without CTX (bar no CTX) before the
conjugation experiment. The results shown are from two biological replicates
and the error bars represent standard deviations. The stars indicate statistical
significance at level: **P ≤ 0.01.
but this time quantifying the number of plasmids in the different
pools relative to the number of bacteria by qPCR (5.0- and
3.1-fold higher transfer frequencies, t-test, p = 0.0037 and
p= 0.0046; Figure 5).
The expression studies revealed that the up-regulation of
tra-genes was dependent on the presence of blaCTX-M-1 in the
strain. In order to determine whether blaCTX-M-1 had to be
located on the resistance plasmid to affect conjugation efficacy,
another conjugation experiment was performed using the strain
MG1655/CTX-M-1/pTF21CTX. This strain carried the CTX-
M-1 encoding gene on the chromosome and a non-coding region
instead of the blaCTX-M-1 on the IncI1 plasmid pTF2. The
experiment showed that the CTX treatment also caused increased
conjugation transfer frequency in this strain with 6.7- and 6.9-
fold higher conjugation transfer frequencies after 30 and 60min
of cell contact, compared to conjugation without pre-growth
in the presence of CTX (t-test, P = 0.0003 and P = 0.0004;
Figure 5).
No proteins associated with the SOS response, such as
LexA or RecA were significantly upregulate in the proteome of
MG1655/pTF2 grown in the presence of high concentrations of
CTX when compared to growth without CTX. This was further
supported by RT-qPCR analysis showing that expression of the
typical SOS-responsive genes, recA and sfiA, were not affected
significantly by growth in the presence of CTX (Supplementary
Figure S3).
DISCUSSION
It is well-established that conjugation plays a major role in the
global spread of antibiotic resistance, and evidence implicating
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FIGURE 5 | Conjugation-transfer-frequencies for MG1655/pTF2 (Left) and MG1655/CTX-M-1/pTF21CTX with the CTX-M-1 gene located on the chromosome
(Right) as measured by qPCR. The donor strains, MG1655/pTF2 or MG1655/CTX-M-1/pTF21CTX, were grown with or without CTX before the conjugation
experiment, and 30 and 60min refers to the time the donor and recipient were having cell contact before the number of trans-conjugants was determined. The results
shown are from three biological replicates and the error bars represent standard deviations. The stars indicate statistical significance at level: **P ≤ 0.01, ***P ≤ 0.001.
antibiotic treatment as a stimulating factor for conjugation
transfer has been presented (Aminov, 2011; Andersson and
Hughes, 2014). It remains unclear if antimicrobial treatment
affects the conjugation efficiency of resistance plasmids directly,
or merely selects for bacteria that have become resistant due
to conjugation, and a recent study by Lopatkin et al. (2016a)
points to a lack of conclusive evidence on this issue, since
conjugation experiments are generally carried out in the presence
of antimicrobials. Thus the experimental setup does not allow
separation of conjugation frequency from selection of resistant
bacteria. This may suggest that the contribution of antibiotics to
the promotion of HGT may have been overestimated (Lopatkin
et al., 2016a,b). In the present study, we avoided the post-
conjugational selection effect by pre-growing donor cells in CTX,
and then performing the conjugation in an antimicrobial free
environment. Furthermore, the conjugation process was only
allowed for 30 or 60min, before vortexing and centrifugation
stopped the process.
We found that genes and corresponding proteins involved
in the conjugation apparatus of an IncI1 resistance plasmid
pTF2 encoding CTX-M-1 were up-regulated in the presence of
high concentrations of CTX. It was furthermore demonstrated
that this up-regulation was associated with an increase in
conjugation frequency in the absence of antimicrobials during
the actual conjugation events. This evidence strongly suggests
that antimicrobials, at least of this type, affects conjugation
efficiency directly in addition to selecting for transconjugants.
Differences to previous observations (Lopatkin et al., 2016a,b)
may be due to other combinations of plasmid and drugs
studied, but it may also rely on our changed experimental setup,
and the fact that high concentrations of drugs, corresponding
to therapeutic concentrations, were used here, while previous
studies have focused on lower concentrations of antimicrobials.
Induction of conjugation transfer gene expression has previously
been described after treatment ofA. hydrofilawith sub-inhibitory
concentrations of tetracycline, trimethoprim and flumequine
(Cantas et al., 2012). Similarly, transfer genes encoded by the
Bacteroides conjugative transposon CTnDOT were found to be
induced by tetracycline and down-regulated in the absence of
the antibiotic (Whittle et al., 2002). Here we report such a
response for the first time for an ESBL plasmid in E. coli treated
with therapeutically relevant concentrations of an antimicrobial
substance.
The experiments were also carried out with a strain in which
the blaCTX-M-1 gene was replaced with a random non-coding
sequence of the same size, maintaining the promoter region.
No induction of tra-genes in response to CTX treatment was
seen in this strain, demonstrating that regulation was dependent
on the presence of the blaCTX-M-1 gene itself, or production
of the gene product, CTX-M-1. Conjugation efficacy was still
significantly increased when the blaCTX-M-1 gene was located on
the chromosome, showing that the resistance gene can contribute
to increased conjugation frequency when located in trans. The
production of CTX-M-1 was highly induced by CTX treatment,
confirming previous reports that expression of CTX-M-1 is
dependent on treatment with the drug (Kjeldsen et al., 2015a).
The exact mechanism by which the resistance gene influences
conjugation frequency remains to be determined. Increased
plasmid conjugative transfer has been reported as a consequence
of the SOS response in E. coli, especially in relation to growth
in the presence of low concentrations of antimicrobials (Sutton
et al., 2000; Baharoglu et al., 2010; Cantas et al., 2012; Lopatkin
et al., 2016b). The SOS-response is a widespread regulatory
network induced by DNA damage, and induction of the SOS
response has been suggested to promote the spread of mobile
genetic elements (Úbeda et al., 2005; Maiques et al., 2006).
None of the SOS response proteins were found to be up-
regulated in the proteomic analysis of MG1655/pTF2 and
the typical SOS-responsive genes, recA and sfiA, were not
induced by growth in the presence of CTX. The lack of
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SOS response induction suggests that changes in conjugation
observed in the current study differs from previously reported
influences of antibiotic treatment on plasmid transfer efficiencies
(Barr et al., 1986; Beaber et al., 2004; Baharoglu et al.,
2010; Cantas et al., 2012). Conjugal transfer of plasmids
from donor to recipient cells is a complex process. Others
factor are involved in conjugal transfer apart from the SOS
response. Miyazaki et al. (2012) reported that in absence
of the stationary phase sigma factor RpoS in Pseudomonas
knackmussii, integrative and conjugative element ICEclc transfer
rates and activation of two key ICEclc promotors (Pint
and PinR) decreased significantly in cells during stationary
phase, suggesting that high RpoS levels are a prerequisite for
activating the ICEclc promoter and thus ICEclc transfer in
P. knackmussii.
In the present study, effect of antimicrobial treatment on
conjugation frequency has been studied in a system, where
selection of transconjugants by the antimicrobial can be
ruled out, and where the effect of a therapeutically relevant
concentration of an antimicrobial has been used. Further
experiments are needed to uncover the underlying mechanism
behind CTX-mediated conjugation induction and to determine
if the observed effect applies to other plasmid types and other
types of antibiotics. This is likely to include detailed studies
of the regulation of the IncI1 transfer genes, as well as the
transfer system of other plasmid types. Overall, the observations
in the study clearly indicate that antibiotic treatment may not
only select for antimicrobial resistant bacteria, but also promote
increased conjugation frequency of resistance plasmids in the gut.
It is important to determine which combination of cephalosporin
treatment and plasmids/ESBL genes that show this response,
since increased conjugation frequency will be an unwanted,
adverse effect of treatment with these potent drugs.
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